Brain

Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience

Dr. Gibson joining Lexaria's new scientific advisor board KELOWNA, BC / ACCESSWIRE / December 17, 2024 / Lexaria Bioscience Corp.…

1 year ago

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.GUILFORD,…

1 year ago

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.GUILFORD,…

1 year ago

Vaccinex Announces Receipt of Delisting Notification from Nasdaq

ROCHESTER, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company…

1 year ago

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

Company’s Exclusive Distribution Agreement with Zimmer Biomet included $3.0 Million Upfront Payment: Expected to Drive Revenue and Expand Margins Significantly…

1 year ago

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review…

1 year ago

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

Single intrathecal dose of Rhenium (186Re) Obisbemeda delivers favorable responses in cerebrospinal fluid circulating tumor cell count, imaging, and clinical…

1 year ago

Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab

NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology…

1 year ago

Exploring Space and Neurotherapeutics at the 2025 Ultrasound Event: A Journey into the Future of Medical Ultrasound

ORLANDO, Fla., Dec. 16, 2024 /PRNewswire/ -- The 2025 AIUM Annual Convention, hosted by the American Institute of Ultrasound in…

1 year ago

Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial

Clinical Trial Demonstrates Superior Metabolic Control During Prolonged Fasting in PKU PatientsResults Expected to Promote Awareness and Adoption of PKU…

1 year ago